[go: up one dir, main page]

NO20003150D0 - FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging - Google Patents

FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging

Info

Publication number
NO20003150D0
NO20003150D0 NO20003150A NO20003150A NO20003150D0 NO 20003150 D0 NO20003150 D0 NO 20003150D0 NO 20003150 A NO20003150 A NO 20003150A NO 20003150 A NO20003150 A NO 20003150A NO 20003150 D0 NO20003150 D0 NO 20003150D0
Authority
NO
Norway
Prior art keywords
chewing
procedure
preparation
tablets dissolved
tablets
Prior art date
Application number
NO20003150A
Other languages
English (en)
Other versions
NO20003150L (no
Inventor
Gopadi M Venkatesh
Nageswara R Palepu
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20003150D0 publication Critical patent/NO20003150D0/no
Publication of NO20003150L publication Critical patent/NO20003150L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003150A 1997-12-19 2000-06-16 FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging NO20003150L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6825897P 1997-12-19 1997-12-19
PCT/US1998/027061 WO1999032092A1 (en) 1997-12-19 1998-12-17 Process for manufacturing bite-dispersion tablets

Publications (2)

Publication Number Publication Date
NO20003150D0 true NO20003150D0 (no) 2000-06-16
NO20003150L NO20003150L (no) 2000-08-11

Family

ID=22081416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003150A NO20003150L (no) 1997-12-19 2000-06-16 FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging

Country Status (20)

Country Link
US (1) US6475510B1 (no)
EP (1) EP1047407A4 (no)
JP (1) JP2001526212A (no)
KR (1) KR100775154B1 (no)
CN (1) CN100379407C (no)
AR (1) AR014133A1 (no)
AU (2) AU1931999A (no)
BR (1) BR9813808A (no)
CA (1) CA2315088A1 (no)
CO (1) CO4990940A1 (no)
HU (1) HUP0100469A2 (no)
IL (2) IL136831A0 (no)
NO (1) NO20003150L (no)
NZ (1) NZ505123A (no)
PL (1) PL197989B1 (no)
SA (1) SA99191111B1 (no)
TR (1) TR200001856T2 (no)
TW (1) TW586943B (no)
WO (1) WO1999032092A1 (no)
ZA (1) ZA9811630B (no)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
ATE316782T1 (de) * 1998-08-21 2006-02-15 Novartis Pharma Gmbh Neue orale formulierungen für 5-ht4 agonisten oder antagonisten
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
WO2000030616A1 (en) * 1998-11-20 2000-06-02 Rtp Pharma Inc. Dispersible phospholipid stabilized microparticles
US7223416B2 (en) * 1999-06-28 2007-05-29 Minu, L.L.C. Topical composition
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
IT1313589B1 (it) * 1999-08-03 2002-09-09 Formenti Farmaceutici Spa Composizioni a rilascio controllato di paracetamolo.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20020022058A1 (en) * 2000-07-08 2002-02-21 Lovercheck Dale R. Unit dose of material in system and method
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
ES2325764T3 (es) 2000-09-22 2009-09-16 Dainippon Sumitomo Pharma Co., Ltd. Preparaciones orales con buenas caracteristicas de desintegracion.
ES2380654T3 (es) * 2000-12-07 2012-05-17 Nycomed Gmbh Tableta de desintegración rápida que comprende un ingrediente activo lábil en medio ácido
WO2002049607A2 (en) * 2000-12-20 2002-06-27 Firmenich Sa Flavoured oral drug delivery system
US20030060451A1 (en) * 2001-05-29 2003-03-27 Rajneesh Taneja Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithin
DE20220604U1 (de) 2001-07-27 2004-02-26 Yamanouchi Pharmaceutical Co., Ltd. Zusammensetzung, enthaltend feine Partikel zur Langzeitfreisetzung für schnell in der Mundhöhle zerfallende Tabletten
US8545887B2 (en) 2001-09-28 2013-10-01 Mcneil-Ppc, Inc. Modified release dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6610266B2 (en) 2001-11-28 2003-08-26 Michael C. Withiam Calcium metasilicates and methods for making
US20030175355A1 (en) * 2002-03-07 2003-09-18 Tobyn Michael John Fast melt multiparticulate formulations for oral delivery
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
JP3444874B1 (ja) * 2002-12-02 2003-09-08 高砂香料工業株式会社 顆粒状香料およびその製造方法
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
FR2848855B1 (fr) * 2002-12-23 2005-02-11 Aventis Pharma Sa Compositions pour administration orale de principes actifs necessitant un masquage du gout
US20040146553A1 (en) * 2002-12-23 2004-07-29 Aventis Pharma S.A. Compositions for oral administration of active principles requiring masking of taste
CN100415269C (zh) * 2002-12-30 2008-09-03 毛友昌 牛黄蛇胆川贝分散片及制备方法
CN1303979C (zh) * 2003-03-21 2007-03-14 毛友昌 蛇胆陈皮分散片及制备方法
WO2004087096A1 (en) * 2003-04-02 2004-10-14 Pliva-Istrazivanje I Razvoj D.O.O. Pharmaceutical compositions having reduced bitter taste
WO2004091582A1 (en) * 2003-04-17 2004-10-28 Ipca Laboratories Limited Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
US7282217B1 (en) * 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
TW200524541A (en) * 2003-11-17 2005-08-01 Cargill Inc Lecithin-containing granular compositions and methods of their preparation
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
US8337887B2 (en) * 2004-03-11 2012-12-25 Laboratories Pharmaceutiques Rodael Rapidly disintegrating taste-masked tablet
PL1732523T3 (pl) 2004-03-30 2010-08-31 Vifor Pharma Tech Ltd Polimery wiążące potas i ich zastosowania
DE602005018619D1 (de) 2004-03-30 2010-02-11 Relypsa Inc Ionenbindende zusammensetzungen
EP1741347A4 (en) * 2004-04-30 2009-09-23 Bio Science Co Ltd FEED ADDITIVE COMPOSITION FOR RETAIL BUYERS, THESE INCLUSIVE FEED AND METHOD FOR PRODUCING A FEED ADDITIVE COMPOSITION FOR REPRODUCTS
MXPA06013608A (es) 2004-05-24 2007-04-26 Nycomed Pharma As Particulado que comprende un compuesto que contiene calcio y un alcohol de azucar.
EA011931B1 (ru) * 2004-06-01 2009-06-30 Никомед Фарма Ас Жевательная таблетка, таблетка для рассасывания и таблетка для глотания, содержащая кальцийсодержащее соединение в качестве активного вещества
PL1750862T3 (pl) * 2004-06-04 2011-06-30 Teva Pharma Kompozycja farmaceutyczna zawierająca irbesartan
US20060024335A1 (en) * 2004-07-29 2006-02-02 Roger Stier E Oral compositions which mask the bitter taste of a bitter-tasting agent
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
ES2255429B1 (es) * 2004-10-25 2007-08-16 Italfarmaco, S.A. Composiciones farmaceuticas bucodispersables.
ITMI20042356A1 (it) * 2004-12-10 2005-03-10 Acraf Composizione farmaceutica orodisperdibile e procedimento per prepararla
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
US20060263429A1 (en) 2005-05-20 2006-11-23 Hengsheng Feng Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
KR20080059265A (ko) 2005-09-30 2008-06-26 일립사, 인코포레이티드 포유동물의 위장관으로부터 칼륨 이온을 선택적으로제거하기 위한 방법 및 조성물
US8586097B2 (en) 2005-09-30 2013-11-19 Relypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
EA015035B1 (ru) * 2005-12-07 2011-04-29 Никомед Фарма Ас Предварительно уплотненные кальцийсодержащие композиции
FR2898492B1 (fr) * 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
CN100502842C (zh) * 2006-08-31 2009-06-24 山东益康药业有限公司 尼扎替丁分散片及其制备方法
EP1952803A1 (en) 2007-01-23 2008-08-06 KTB-Tumorforschungs GmbH Solid pharmaceutical dosage form containing hydrogenated phospholipids
WO2008104996A2 (en) * 2007-02-28 2008-09-04 Jubilant Organosys Limited Water dispersible pharmaceutical formulation and process for preparing the same
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
JP2008297277A (ja) * 2007-06-01 2008-12-11 Taiyo Yakuhin Kogyo Kk 注射剤の安定化法
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
TWI592159B (zh) 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
WO2009150665A1 (en) * 2008-06-09 2009-12-17 Lupin Limited Orally disintegrating pharmaceutical compositions of escitalopram and salts thereof
PL2389077T3 (pl) * 2009-01-23 2015-11-30 Wyeth Llc Suplementy diety dla ludzi 50+ do polepszania witalności, odporności, zdrowia oczu i kości
WO2011066428A1 (en) * 2009-11-25 2011-06-03 Cargill, Incorporated Sweetener compositions and methods of making the same
AU2010325746B2 (en) * 2009-12-02 2016-02-25 Adare Pharmaceuticals S.R.L. Fexofenadine microcapsules and compositions containing them
WO2012079118A1 (en) 2010-12-13 2012-06-21 Borody Thomas J Gastric and colonic formulations and methods for making and using them
US20120276199A1 (en) * 2011-04-01 2012-11-01 Dr. Reddy's Laboratories Limited Taste masked pharmaceutical formulations
EP2742350B1 (en) 2011-08-08 2019-10-30 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
DE102011115173A1 (de) * 2011-08-12 2013-02-14 Ipc Process-Center Gmbh & Co. Kg Koffein enthaltendes Granulat und Verfahren zu seiner Herstellung
WO2013175511A1 (en) * 2012-05-24 2013-11-28 V.B. Medicare Pvt. Ltd. Taste masked pharmaceutical compositions
US10166219B2 (en) * 2012-07-27 2019-01-01 Redhill Bipharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
CN104366313A (zh) * 2013-08-15 2015-02-25 珠海市红旌发展有限公司 一种红薯叶咀嚼片
CA2988495C (en) 2015-06-18 2022-02-08 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
SI3106148T1 (en) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S.A. ORODISPERSIBILITY DOSING UNIT, CONTAINING ESTETROL COMPONENT
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
JP6145954B1 (ja) * 2016-09-06 2017-06-14 株式会社東洋新薬 飲食用組成物
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US11096894B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11058633B2 (en) * 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US10925853B2 (en) 2019-04-17 2021-02-23 Nordiccan A/S Oral cannabinoid tablet
CA3239786A1 (en) * 2021-12-03 2023-06-08 Kapish KARAN An organic chewable composition comprising certified organic ingredients, and process for preparing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
CN1055877A (zh) * 1990-04-20 1991-11-06 国家医药管理局上海医药工业研究院 中药咀嚼片的制备方法
US5861172A (en) 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
CA2130487A1 (en) * 1992-02-18 1993-08-19 Kouichi Nakamichi Fast soluble tablet
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
JP2841267B2 (ja) * 1993-12-17 1998-12-24 エスエス製薬株式会社 イブプロフェン含有粒剤
US5529783A (en) * 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
ES2142601T3 (es) * 1995-07-31 2000-04-16 Gerhard Gergely Comprimido masticable con accion efervescente.
DE19534368A1 (de) * 1995-09-15 1997-03-20 Pedex & Co Gmbh Borsten mit Oberflächenstruktur und Verfahren zu ihrer Herstellung
FR2786665B1 (fr) * 1998-12-08 2001-02-23 Maurel Sante Compositions de type fondant a base de polyols, compositions pharmaceutiques et complements alimentaires incluant de telles compositions et leurs procedes de preparation

Also Published As

Publication number Publication date
PL341353A1 (en) 2001-04-09
ZA9811630B (en) 1999-06-21
SA99191111B1 (ar) 2006-10-11
SA99191111A (ar) 2005-12-03
BR9813808A (pt) 2002-05-28
EP1047407A1 (en) 2000-11-02
HUP0100469A2 (hu) 2001-08-28
IL136831A0 (en) 2001-06-14
IL136831A (en) 2006-12-10
KR20010033328A (ko) 2001-04-25
TW586943B (en) 2004-05-11
NO20003150L (no) 2000-08-11
PL197989B1 (pl) 2008-05-30
US6475510B1 (en) 2002-11-05
NZ505123A (en) 2003-07-25
CO4990940A1 (es) 2000-12-26
AU2002300238B2 (en) 2003-01-02
CA2315088A1 (en) 1999-07-01
KR100775154B1 (ko) 2007-11-12
CN1284867A (zh) 2001-02-21
CN100379407C (zh) 2008-04-09
AU1931999A (en) 1999-07-12
AR014133A1 (es) 2001-02-07
JP2001526212A (ja) 2001-12-18
WO1999032092A1 (en) 1999-07-01
AU2002300238C1 (en) 2004-03-04
TR200001856T2 (tr) 2000-11-21
EP1047407A4 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
NO20003150L (no) FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging
NO20005043L (no) Formulering av hurtigoppløsende efavirenz-kapsler eller - tabletter som benytter super-desintegreringsmidler
NO994771D0 (no) FremgangsmÕte ved fremstilling av oligosakkarider
NO971137D0 (no) Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser
NO20004288L (no) FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO993949D0 (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
NO20002247D0 (no) FremgangsmÕte for fremstilling av aromatiske nitroforbindelser
NO993912D0 (no) Fremgangsmåte for fremstilling av eprosartan
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO993913D0 (no) Fremgangsmåte for fremstilling av eprosartan
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
NO994131D0 (no) Fremgangsmåte for fremstilling av benzotiazolonforbindelser
NO20003393L (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
DK1012143T3 (da) Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20005743D0 (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- oksyglukoronider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application